Cogent Biosciences, Inc. (COGT) › Shareholders' EquityCogent Biosciences, Inc. (COGT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$24.70M2017: -$48.85M2018: $60.23M2019: $31.76M2020: $234.67M2021: $214.18M2022: $255.74M2023: $257.80M2024: $256.29M2025: $636.37M$636.37M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$636.37M+148.3%2024$256.29M-0.6%2023$257.80M+0.8%2022$255.74M+19.4%2021$214.18M-8.7%2020$234.67M+638.8%2019$31.76M-47.3%2018$60.23M+223.3%2017-$48.85M-97.8%2016-$24.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share